Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NUTX Stock Forecast 2026-2027
$164.40
Current Price
$1.23B
Market Cap
Buy 5
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to NUTX Price Targets
+82.5%
To High Target of $300.00
+42.9%
To Median Target of $235.00
+6.4%
To Low Target of $175.00
NUTX Price Momentum
-10.6%
1 Week Change
+12.3%
1 Month Change
+48.4%
1 Year Change
-0.1%
Year-to-Date Change
-19.4%
From 52W High of $204.00
+112.9%
From 52W Low of $77.21
📊 TOP ANALYST CALLS
Did NUTX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Nutex Health is one of their latest high-conviction picks.
Latest NUTX Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, NUTX has a bullish consensus with a median price target of $235.00 (ranging from $175.00 to $300.00). The overall analyst rating is Strong Buy (9.6/10). Currently trading at $164.40, the median forecast implies a 42.9% upside. This outlook is supported by 5 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NUTX Analyst Ratings
5
Buy
0
Hold
0
Sell
NUTX Price Target Range
Low
$175.00
Average
$235.00
High
$300.00
Current: $164.40
Latest NUTX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NUTX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 26, 2026 | B. Riley Securities | Anderson Schock | Buy | Initiates | $290.00 |
| Jun 2, 2026 | Lake Street | Buy | Initiates | $N/A | |
| Aug 26, 2025 | Maxim Group | Buy | Maintains | $N/A | |
| Jul 10, 2025 | Benchmark | Buy | Reiterates | $N/A | |
| May 20, 2025 | Maxim Group | Buy | Maintains | $N/A | |
| May 15, 2025 | Benchmark | Buy | Maintains | $N/A | |
| Apr 9, 2025 | Benchmark | Buy | Maintains | $N/A | |
| Apr 8, 2025 | Maxim Group | Buy | Maintains | $N/A | |
| Feb 13, 2025 | Maxim Group | Buy | Maintains | $N/A | |
| Nov 12, 2024 | Maxim Group | Buy | Maintains | $N/A | |
| Nov 12, 2024 | Benchmark | Buy | Maintains | $N/A | |
| Sep 18, 2024 | Maxim Group | Buy | Initiates | $N/A | |
| Aug 21, 2024 | Benchmark | Buy | Maintains | $N/A | |
| Jan 25, 2024 | Benchmark | Buy | Maintains | $N/A | |
| Nov 14, 2023 | Benchmark | Buy | Maintains | $N/A | |
| Aug 29, 2023 | Benchmark | Buy | Reiterates | $N/A | |
| May 17, 2023 | Benchmark | Buy | Maintains | $N/A | |
| Mar 9, 2023 | Benchmark | Buy | Reiterates | $N/A | |
| Dec 23, 2022 | Benchmark | Buy | Initiates | $N/A |
Nutex Health Inc. (NUTX) Competitors
The following stocks are similar to Nutex Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nutex Health Inc. (NUTX) Financial Data
Nutex Health Inc. has a market capitalization of $1.23B with a P/E ratio of 13.5x. The company generates $879.95M in trailing twelve-month revenue with a 11.0% profit margin.
Revenue growth is +2.2% quarter-over-quarter, while maintaining an operating margin of +37.5% and return on equity of +53.6%.
Valuation Metrics
Market Cap
$1.23B
Enterprise Value
$1.50B
P/E Ratio
13.5x
PEG Ratio
0.2x
Price/Sales
1.4x
Growth & Margins
Revenue Growth (YoY)
+2.2%
Gross Margin
+42.4%
Operating Margin
+37.5%
Net Margin
+11.0%
EPS Growth
+120.6%
Financial Health
Cash/Price Ratio
+18.3%
Current Ratio
3.1x
Debt/Equity
79.0x
ROE
+53.6%
ROA
+28.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Nutex Health Inc. (NUTX) Business Model
About Nutex Health Inc.
What They Do
Provides technology-enabled healthcare management solutions.
Business Model
The company generates revenue through three main divisions: the Hospital Division, which operates micro-hospitals and specialty hospitals; the Population Health Management Division, which manages provider networks and offers management services; and the Real Estate Division, which leases properties to healthcare entities. This diversified model allows Nutex Health to optimize patient care while effectively managing operational costs.
Additional Information
Founded in 2011 and based in Houston, Texas, Nutex Health Inc. operates over 24 facilities across 11 states, focusing on innovative care models that provide 24/7 emergency and specialized services. The company's emphasis on value-based care and technology integration positions it as a competitive player in the healthcare sector.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
1,005
CEO
Dr. Thomas T. Vo M.B.A., M.D.
Country
United States
IPO Year
2013
Website
www.nutexhealth.comNutex Health Inc. (NUTX) Latest News & Analysis
Latest News
Quick Summary
Nutex Health (NUTX) is rated Buy, with a price target of $199.31, indicating 19.8% upside. Revenue is projected to rise from $247.6M in FY2023 to $880.0M by March 31, 2026, with improved liquidity metrics.
Why It Matters
Nutex Health's strong revenue growth, improved liquidity, and favorable debt metrics indicate financial health, with a significant upside potential in its stock price, making it an attractive investment opportunity.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Kuehn Law is investigating potential fiduciary duty breaches by officers and directors of Nutex Health, Inc. (NASDAQ: NUTX), which may impact shareholder interests.
Why It Matters
The investigation into Nutex Health's officers and directors may signal potential legal troubles, impacting investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Nutex Health Inc. (NUTX) held its Q1 2026 earnings call, discussing financial performance and strategic updates. Further details can be found in the full transcript.
Why It Matters
Nutex Health's earnings call provides insights into financial performance and future outlook, influencing investor sentiment and potential stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Nutex Health Inc. (NASDAQ: NUTX) reported financial results for Q1 2026, operating 27 hospital facilities across 12 states and a risk-bearing physician network.
Why It Matters
Nutex Health's Q1 2026 financial results reflect its operational performance and growth potential, impacting investor sentiment and valuation in the healthcare sector.
Source: PRNewsWire
Market Sentiment:
Neutral
Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call
2 months ago
Quick Summary
Nutex Health, Inc. (NASDAQ: NUTX) will file its Q1 2026 Form 10-Q on April 30, 2026, after market close, along with a press release detailing financial results.
Why It Matters
Nutex Health's upcoming Form 10-Q filing and financial results release could significantly influence stock performance, impacting investor sentiment and market valuation.
Source: PRNewsWire
Market Sentiment:
Neutral
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX
3 months ago
Quick Summary
Pomerantz LLP is investigating claims for Nutex Health, Inc. (NASDAQ: NUTX) investors. Interested parties should contact Danielle Peyton at [email protected] or 646-581-9980.
Why It Matters
The investigation into Nutex Health by Pomerantz LLP may indicate potential legal issues or financial mismanagement, which could impact the company's stock value and investors' holdings.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About NUTX Stock
What is Nutex Health Inc.'s (NUTX) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, Nutex Health Inc. (NUTX) has a median price target of $235.00. The highest price target is $300.00 and the lowest is $175.00.
Is NUTX stock a good investment in 2027?
According to current analyst ratings, NUTX has 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $164.40. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NUTX stock?
Wall Street analysts predict NUTX stock could reach $235.00 in the next 12 months. This represents a 42.9% increase from the current price of $164.40. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Nutex Health Inc.'s business model?
The company generates revenue through three main divisions: the Hospital Division, which operates micro-hospitals and specialty hospitals; the Population Health Management Division, which manages provider networks and offers management services; and the Real Estate Division, which leases properties to healthcare entities. This diversified model allows Nutex Health to optimize patient care while effectively managing operational costs.
What is the highest forecasted price for NUTX Nutex Health Inc.?
The highest price target for NUTX is $300.00 from at , which represents a 82.5% increase from the current price of $164.40.
What is the lowest forecasted price for NUTX Nutex Health Inc.?
The lowest price target for NUTX is $175.00 from at , which represents a 6.4% increase from the current price of $164.40.
What is the overall NUTX consensus from analysts for Nutex Health Inc.?
The overall analyst consensus for NUTX is bullish. Out of 2 Wall Street analysts, 5 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $235.00.
How accurate are NUTX stock price projections?
Stock price projections, including those for Nutex Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 2:57 AM UTC